Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 16 pp 16021—16034

Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway

class="figure-viewer-img"

Figure 1. DLX6-AS1 was up-regulated in BC tissues and cell lines. (A) The DLX6-AS1 expression in 60 cases of BC tissues and adjacent normal tissues were determined by qRT-PCR. (B) The relationship of 5 year survival rate of the BC patients with high (n=27) or low (n=33) DLX6-AS1 expression were analyzed by Kaplan-Meier’s method and the log-rank test. (C) The expression of DLX6-AS1 in BC tissues and normal tissues was determined by ISH assay. (D) The mRNA expression level of DLX6-AS1 in a human bladder epithelium immortalized cell line (SV-HUC-1) and five BC cell lines (T24, RT4, 5637, J82, and SW780) was determined by qRT-PCR. The DLX6-AS1 was highly expressed in BC cells. Data were expressed as the mean ± SD. ***P < 0.001 vs SV-HUC-1.